We source the “rare gems” of HealthTech to transform them into high-performing startups.
Our proactive and collaborative approach allows us to build solid and promising startups, ready to face market challenges and seize growth opportunities. We firmly believe that this strategy creates innovative, prosperous companies capable of transforming their sector.
1 - Project identification and qualification
We are present in the field with French and European academic and hospital actors. We identify and qualify more than 400 innovative projects each year. Our selection process results in the creation of 1 to 2 startups per year. We choose the best innovations and strive to build the successful startups of tomorrow.
2 -Pre-creation exploration
Before committing to creating the startup and investing, we take the time to explore the technological assets, risks, and opportunities of each project upstream. We anticipate issues related to intellectual property, clinical and regulatory developments, industrialization, and market access.
We focus on building the startup by developing a detailed development plan, a clear roadmap, securing the necessary funding, and assembling a solid and competent team to carry out the project. To do this, we rely on the active support of our ecosystem. This includes industry experts, entrepreneurs, large groups, academic networks, and healthcare professionals.
3 - Creation and investment
In addition to financially investing in startups, we also dedicate our time and expertise, transforming our human value into capital.
We form a cohesive team with project leaders, capable of bringing the key skills to launch and develop the project’s initial stages. We can assume the role of CEO depending on the context.
We remain operationally involved until Series A, according to the specific needs of the startup, preparing the operational transition.
We finance the very early stages of project development and optimize the non-dilutive leverage effect, ensuring a solid foundation for future growth.
4 - Financing and exit
We value each key milestone of the project, based on the progress and successes achieved. At each stage, we strive to find the most relevant co-investors among seed and Series A funds to finance the development phases.
We identify potential acquirers of our startups from the outset, allowing us to prepare strategic exits from the creation phase. By integrating these exit scenarios from the beginning, we ensure that our startups are ready to seize market opportunities and maximize their impact.
